Developing effective prevention technologies for abdominal adhesions could revolutionize surgical outcomes.

• Current strategies are limited; many have not translated to patient care.
• Successful prevention must address immune responses, coagulation, and peritoneal cell activity.

Focus on clinically valid animal models will be crucial for future approvals.

• Handling characteristics of existing products hinder their use in surgery.